Skip to content

Pharmentum: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Pharmentum

BE 0699.939.132
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€37,252
2024 · -€52,200+€14,948
Equity
€303,300
2024 · €340,551-€37,252
Cash
€1,322
2024 · €6,018-€4,696
Balance sheet total
€1.2m
2024 · €1.2m-€77,503

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€200,852

    down €200,852 (-94.6%), from €212,406 to €11,554

    of which Trade receivables: -€201,576

  • Financial fixed assets +€141,307

    up €141,307 (+15.4%), from €919,143 to €1.1m

  • Deferred charges and accrued income -€13,262

    down €13,262 (-98.9%), from €13,416 to €154

Equity and liabilities
  • Debts after one year -€107,805

    down €107,805 (-39.7%), from €271,618 to €163,813

  • Trade debts +€53,110

    up €53,110 (+10.4%), from €509,607 to €562,717

  • Profit (loss) carried forward -€37,252

    down €37,252 (-15.5%), from €240,551 to €203,300

  • Tax, wage and social debts +€24,008

    up €24,008 (+816%), from €2,943 to €26,951

Income statement
  • Financial income +€21,353

    new in 2025: €21,353

  • Gross operating margin -€12,445

    down €12,445 (-23.3%), from €53,328 to €40,883

  • Financial charges -€3,229

    down €3,229 (-22.8%), from €14,183 to €10,954

  • Staff costs -€3,003

    down €3,003 (-3.4%), from €88,629 to €85,626

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€52,200
Gross operating margin -€12,445
Staff costs +€3,003
Other operating charges -€74
Financial income +€21,353
Financial charges +€3,229
Taxes -€117
Result 2025 -€37,252
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€256,294
Investment -€141,307
Financing -€119,684
Cash 2024 €6,018
Net result for the year -€37,252
Receivables within one year +€200,852
Deferred charges and accrued income +€13,262
Trade debts +€53,110
Tax, wage and social debts +€24,008
Accrued charges and deferred income +€2,314
Investment in fixed assets (net) -€141,307
Debts after one year -€107,805
Current portion of long-term debt -€11,879
Cash 2025 €1,322
brings cash intakes cash out
Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,246,988 €1,169,484 -€77,503 -6.2%
Fixed assets 21/28 €919,143 €1,060,450 +€141,307 +15.4%
Financial fixed assets 28 €919,143 €1,060,450 +€141,307 +15.4%
Current assets 29/58 €327,845 €109,035 -€218,810 -66.7%
Amounts receivable after more than one year 29 €96,005 €96,005 = 0.0%
Other amounts receivable 291 €96,005 €96,005 = 0.0%
Amounts receivable within one year 40/41 €212,406 €11,554 -€200,852 -94.6%
Trade receivables 40 €211,845 €10,269 -€201,576 -95.2%
Other amounts receivable 41 €560 €1,285 +€724 +129%
Cash at bank and in hand 54/58 €6,018 €1,322 -€4,696 -78.0%
Deferred charges and accrued income 490/1 €13,416 €154 -€13,262 -98.9%
Total equity and liabilities 10/49 €1,246,988 €1,169,484 -€77,503 -6.2%
Equity 10/15 €340,551 €303,300 -€37,252 -10.9%
Contributions 10/11 €100,000 €100,000 = 0.0%
Capital 10 €100,000 €100,000 = 0.0%
Issued capital 100 €100,000 €100,000 = 0.0%
Profit (loss) carried forward 14 €240,551 €203,300 -€37,252 -15.5%
Amounts payable 17/49 €906,436 €866,185 -€40,251 -4.4%
Amounts payable after more than one year 17 €271,618 €163,813 -€107,805 -39.7%
Financial debts 170/4 €271,618 €163,813 -€107,805 -39.7%
Amounts payable within one year 42/48 €634,818 €700,058 +€65,240 +10.3%
Current portion of amounts payable after more than one year 42 €122,268 €110,389 -€11,879 -9.7%
Trade debts 44 €509,607 €562,717 +€53,110 +10.4%
Suppliers 440/4 €509,607 €562,717 +€53,110 +10.4%
Taxes, remuneration and social security 45 €2,943 €26,951 +€24,008 +816%
Taxes 450/3 €2,943 €26,951 +€24,008 +816%
Accrued charges and deferred income 492/3 - €2,314 +€2,314
Remuneration, social security and pensions 62 €88,629 €85,626 -€3,003 -3.4%
Other operating charges 640/8 €2,716 €2,790 +€74 +2.7%
Gross operating margin 9900 €53,328 €40,883 -€12,445 -23.3%
Operating profit (loss) 9901 -€38,017 -€47,533 -€9,516 -25.0%
Financial income 75/76B - €21,353 +€21,353
Recurring financial income 75 - €21,353 +€21,353
Financial charges 65/66B €14,183 €10,954 -€3,229 -22.8%
Recurring financial charges 65 €14,183 €10,954 -€3,229 -22.8%
Profit (loss) for the period before taxes 9903 -€52,200 -€37,135 +€15,065 +28.9%
Income taxes 67/77 - €117 +€117
Profit (loss) for the period 9904 -€52,200 -€37,252 +€14,948 +28.6%
Profit (loss) for the period to be appropriated 9905 -€52,200 -€37,252 +€14,948 +28.6%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.